Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,151
Recruiting: 2,258
Ph III recruiting: 267
Growth YoY: +13.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 1,951–1,957 of 1,957 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00518557	Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis(TACE HCC)	unknown	N/A	60	Southeast University, ChinaOTHER	1	Jan 22, 2009	clinicaltrials
NCT00230139	SPECT/CT in Endocrine and Neuroendocrine Tumors	completed	N/A	200	Rambam Health Care CampusOTHER	1	Oct 15, 2008	clinicaltrials